Midsun Pharmaceuticals Private Limited
About Midsun Pharmaceuticals Private Limited
Data last updated:
Midsun Pharmaceuticals Private Limited is a private limited company based in Yeshwanthpur, Karnataka, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 04 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2018PTC111925. Its GSTIN is 32AALCM7444G1ZE (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Arunlal Gopi and Yoosaf Faizal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Yeshwanthpur, Karnataka.
As per the financials filed for FY 2025, the company reported a revenue of ₹22.59 Lakh, a growth of 62% compared to the previous year. For the same year it recorded a net profit of ₹14,022 (net margin 0.6%) and EBITDA of ₹20,030 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 76% over three years and 65% over five years.
Company details
Contact details
Midsun Pharmaceuticals Private Limited's registered office is in Yeshwanthpur, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressRoom No:104 Site No: A – 20 D Devaraja Urs Truck Terminal Industria, L Suburb, Yeshwanthpur, Karnataka, India – 560022
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Midsun Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Midsun Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Midsun Pharmaceuticals Private Limited, buy the company report.
Financials of Midsun Pharmaceuticals Private Limited
FY 2025 filings availableMidsun Pharmaceuticals Private Limited reported revenue of ₹22.59 Lakh (up 62% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 65% over five years, including 62% growth in the latest year. EBITDA rose 72% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,030 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14,022 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Midsun Pharmaceuticals Private Limited, buy the company report.
Board of directors of Midsun Pharmaceuticals Private Limited
Midsun Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arunlal Gopi | Director | 04 Apr 2018 | 8 Years 7 Months | Current |
| Yoosaf Faizal | Director | 04 Apr 2018 | 8 Years 7 Months | Current |
| Sumithra Sasidharan | Director | 04 Apr 2018 | 8 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Midsun Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Midsun Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Midsun Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AALCM7444G1ZE | Kerala | Active | 03 Jul 2018 |
To see the full GST registrations and return filing status of Midsun Pharmaceuticals Private Limited, buy the company report.
Recent activity
Midsun Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Arunlal Gopi was appointed as Director on 04 Apr 2018.
Frequently asked questions
Midsun Pharmaceuticals is an active private limited company based in Yeshwanthpur, Karnataka, India. The company works in specialty, within the trading industry. It was incorporated on 04 April 2018 (8+ years old) and is registered under CIN U51909KA2018PTC111925.
Midsun Pharmaceuticals has 3 current directors:
- Arunlal Gopi - Director
- Yoosaf Faizal - Director
- Sumithra Sasidharan - Director
The latest financial statements of Midsun Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Midsun Pharmaceuticals is 32AALCM7444G1ZE, registered in Kerala.
The CIN (Corporate Identification Number) of Midsun Pharmaceuticals is U51909KA2018PTC111925. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Midsun Pharmaceuticals was incorporated on 04 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Arunlal Gopi was appointed as Director on 04 Apr 2018. Sumithra Sasidharan was appointed as Director on 04 Apr 2018. Yoosaf Faizal was appointed as Director on 04 Apr 2018.
The registered office of Midsun Pharmaceuticals is at Room No:104 Site No: A – 20 D Devaraja Urs Truck Terminal Industria, L Suburb, Yeshwanthpur, Karnataka, India – 560022.
Midsun Pharmaceuticals operates in the trading industry, in the specialty segment.
Midsun Pharmaceuticals can be reached at its registered office: Room No:104 Site No: A – 20 D Devaraja Urs Truck Terminal Industria, L Suburb, Yeshwanthpur, Karnataka, India – 560022.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
